Siddiqi, T
Important safety considerations include a boxed warning for thyroid C-cell tumors, contraindication in patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and precautions regarding pregnancy (not recommended), reduced oral contraceptive effectiveness, and risks of pancreatitis, gallbladder disease, and acute kidney injury
To secure the potency and stability of formulation, weighing machine must work efficiently
There is also a boxed warning about thyroid C-cell tumors based on animal studies
Compared to Retatrutide, Mounjaros side effects are better tracked and understood
The medication activates GLP-1 receptors to suppress appetite, slow stomach emptying, and improve blood sugar levels